ATE67091T1 - Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis. - Google Patents

Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis.

Info

Publication number
ATE67091T1
ATE67091T1 AT86300720T AT86300720T ATE67091T1 AT E67091 T1 ATE67091 T1 AT E67091T1 AT 86300720 T AT86300720 T AT 86300720T AT 86300720 T AT86300720 T AT 86300720T AT E67091 T1 ATE67091 T1 AT E67091T1
Authority
AT
Austria
Prior art keywords
manufacture
treatment
drug
viral hepatitis
hepatitis
Prior art date
Application number
AT86300720T
Other languages
English (en)
Inventor
Irving Millman
Pinayur S Venkateswaran
Baruch S Blumberg
Original Assignee
Fox Chase Cancer Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fox Chase Cancer Center filed Critical Fox Chase Cancer Center
Application granted granted Critical
Publication of ATE67091T1 publication Critical patent/ATE67091T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/47—Euphorbiaceae (Spurge family), e.g. Ricinus (castorbean)

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT86300720T 1985-04-26 1986-02-03 Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis. ATE67091T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/727,452 US4673575A (en) 1985-04-26 1985-04-26 Composition, pharmaceutical preparation and method for treating viral hepatitus
EP19860300720 EP0199429B1 (de) 1985-04-26 1986-02-03 Herstellung eines Arzneimittels für die Behandlung von viraler Hepatitis

Publications (1)

Publication Number Publication Date
ATE67091T1 true ATE67091T1 (de) 1991-09-15

Family

ID=24922713

Family Applications (1)

Application Number Title Priority Date Filing Date
AT86300720T ATE67091T1 (de) 1985-04-26 1986-02-03 Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis.

Country Status (6)

Country Link
US (1) US4673575A (de)
EP (1) EP0199429B1 (de)
AT (1) ATE67091T1 (de)
AU (1) AU593547B2 (de)
CA (1) CA1268712A (de)
DE (1) DE3681323D1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4937074A (en) * 1988-03-29 1990-06-26 Fox Chase Cancer Center Method of treating retrovirus infection
US5648089A (en) * 1995-07-03 1997-07-15 Shawkat; Tarek Extract solution and herbal mixture for treatment of hepatitis
JP3249136B2 (ja) * 1996-08-16 2002-01-21 ヘパガード・カンパニー・リミテッド フィラントゥス ウスリエンシスおよび／またはフィラントゥス ウリナリアの抽出物を含むｂ型肝炎治療用医薬組成物
EP0890360B1 (de) * 1997-04-21 2003-01-02 Dabur Research Foundation Polypflanzliche pharmazeutische Zusammensetzungen geeignet in der Behandlung der Hepatitis E und Hepatitis B Virus-Infektion zusammenhängenden Zustände
JP2002523408A (ja) 1998-08-25 2002-07-30 イェール ユニバーシティ ヘリオキサンチンおよびその類似体によるｂ型肝炎ウイルスおよびフラビウイルスの阻害および治療
AU4947700A (en) * 1999-03-24 2000-10-09 Southern Petrochemical Industries Corporation Limited An enriched fraction prepared from phyllanthus amarus for the treatment of hepatitis and the preparation thereof
DE19919585A1 (de) 1999-04-29 2000-12-07 Cmi Ag Verwendung von Phyllanthus zur Behandlung von oxidativem Streß und anderen Symptomen
DE10014674B4 (de) * 2000-03-24 2005-01-27 Council Of Scientific And Industrial Research (C.S.I.R.) Verfahren für die Extraktion und Isolierung von Phyllanthin
ATE322278T1 (de) * 2000-10-06 2006-04-15 Phytrix Ag Verbindungen aus phyllanthus zur prävention und/oder behandlung von erkrankungen im zusammenhang mit einem retrovirus
WO2002030436A1 (de) * 2000-10-06 2002-04-18 Cmi - Centers For Medical Innovation Ag Verfahren zur herstellung von phyllanthusextrakten
DE10120627A1 (de) * 2001-04-26 2002-10-31 Cmi Ag Verwendung von Phyllanthusbestandteilen zur Behandlung oder Prophylaxe von Infekten durch Hepatitis B-Viren
DE10155517A1 (de) * 2001-11-13 2003-05-28 Metanomics Gmbh & Co Kgaa Verfahren zur Extraktion von Inhaltsstoffen aus organischem Material

Also Published As

Publication number Publication date
EP0199429A3 (en) 1988-02-24
CA1268712A (en) 1990-05-08
DE3681323D1 (de) 1991-10-17
AU593547B2 (en) 1990-02-15
US4673575A (en) 1987-06-16
EP0199429B1 (de) 1991-09-11
AU5653086A (en) 1986-10-30
EP0199429A2 (de) 1986-10-29

Similar Documents

Publication Publication Date Title
ATE67091T1 (de) Herstellung eines arzneimittels fuer die behandlung von viraler hepatitis.
DK0662157T3 (da) Præparater og fremgangsmåde til behandling af Hepatitis C-virus-associerede sygdomme
NL186239B (nl) Werkwijze voor de bereiding van een geneesmiddel met antiflogistische en/of analgetische werking, alsmede werkwijze voor de bereiding van een 2-hydroxyethylideencyaanazijnzuuranilide geschikt voor toepassing bij deze werkwijze.
DK0594607T3 (da) Forøgelse af nedreguleringen af autoimmune sygdomme ved oral eller enteral indgivelse af autoantigener
FR2481703B1 (fr) Acides aminocyclopentane-alcenoiques et leurs esters, leur preparation et utilisation dans des compositions pharmaceutiques
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
NL7702784A (nl) Werkwijze voor het zuiveren en isoleren van he- patitisvirus ten gebruike bij de bereiding van een vaccin.
DE3174807D1 (en) Pharmaceutical composition
DE3879873D1 (de) Physiologisch aktive substanzen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
GEP20084377B (en) Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections
ATE302944T1 (de) Verfahren zum screening von arzneizubereitungen
DK430989A (da) Transdermalt anvendeligt laegemiddel med et indhold af farmaceutisk anvendelige glykosider
ES2036526T3 (es) Composiciones de interferon.
DE69534039D1 (de) Verwendung von valin zur herstellung eines medikaments zur leberregeneration
BE847685A (fr) Preparations retard en solution huileuse non saturee, et leur procede de preparation
Padma et al. Hepatoprotective activity of Annona muricata Linn. and Polyalthia cerasoides bedd.
EP0342565A3 (de) Verwendung des Thiazol-Derivates Tiprotimod zur Herstellung eines Mittels zur Therapie von Virusinfektionen
DE59000712D1 (de) Extrakt arzneimittel.
RU2003126207A (ru) Средство для лечения вирусного гепатита с
KR950702838A (ko) 인터루킨-4(IL-4)를 사용한 사람 면역결핍 바이러스(HIV) 복제의 억제방법(Method for inhibiting HIV replication using IL-4)
EP0642793A4 (en) Apoptosis inducer.
JPS5247980A (en) Method of preparing new nuclease
KR950023413A (ko) 화분 추출물을 포함하는 비(b)형 간염 치료제
RU97102277A (ru) Способ проведения гемосорбции
Matsueda et al. Therapeutical effect of chlorella to human serum pseudocholinesterase.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties